Chang Yi Wang

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Atsumoo (talk | contribs) at 03:09, 31 October 2022 (Added links. Grammar edits.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Chang Yi Wang (王長怡)
Born (1951-12-19) December 19, 1951 (age 72)
Alma mater
Known for
SpouseNean Hu
ChildrenMei Mei Hu
Scientific career
Institutions
Doctoral advisorHenry Kunkel
Other academic advisors

Chang Yi Wang (traditional Chinese: 王長怡; simplified Chinese: 王长怡; pinyin: Wángzhǎngyí; IPA: [tʃɒ̌ŋ jí wɒ́ŋ]) is the founder of United Biomedical, Inc. (UBI), headquartered in Hauppauge, New York, and its group of companies in Asia.

Wang was born in Taiwan in 1951.[1] Her father was a member of the National Assembly. She majored in organic chemistry when she was doing her undergraduate at the National Taiwan University, and then went to Rockefeller University for her doctorate degree. In 1985, Wang founded United Biomedical, Inc. in New York whose main focus is on medicine and vaccine development.[2] She founded United Biomedical, Inc. Asia in Taiwan in 1998.[1]

Wang is the author of more than 120 peer-reviewed scientific publications, and she is the inventor of more than 80 patents to date.[3] In 2007, the New York Intellectual Property Law Association (NYIPLA) presented Wang with the Inventor of the Year Award.[4] In 2018, the Brain Mapping Foundation presented Wang with the Pioneer in Technology Award.[5]

Early life and education

Wang graduated with honors from the National Taiwan University in 1973, majoring in chemistry. She received her Ph.D. degree from Rockefeller University with a dual specialization in Biochemistry and Immunology in 1979 and then joined the Memorial Sloan Kettering Cancer Center as the youngest faculty member, principal investigator, and head of the molecular immunology laboratory.[6]

Career in immunology and entrepreneurship in the biomedical industry

Chang Yi Wang also founded UBI Asia subsidiary companies in Asia: United Biopharma and UBI Pharma in 2013 and 2014 respectively.[7][8]

In 2009, the Bill and Melinda Gates Foundation awarded Grand Challenges Exploration Grants to Chang Yi Wan for the Synthetic Peptides to Inhibit HIV Entry program.[9]

Professional and honorary affiliations

References

  1. ^ a b "王長怡×王瑞瑜 突破台灣生技盲點|天下雜誌". 天下雜誌 (in Chinese (Taiwan)). Retrieved October 6, 2019.
  2. ^ "人物側寫-8萬美元起家 王長怡 締造生技業奇蹟 - 財經要聞". 中時電子報 (in Chinese). Retrieved October 6, 2019.
  3. ^ "Publication". www.unitedbiomedical.com. Publication. Retrieved October 7, 2019.
  4. ^ "United Biomedical, Inc. CEO Dr. Chang Yi Wang named Inventor of the Year 2007 by New York Intellectual Property Law Association". NewsRx. June 17, 2007. Archived from the original on September 28, 2011. Retrieved August 5, 2011.
  5. ^ "Pioneer in Technology Award". www.worldbrainmapping.org. Retrieved October 7, 2019.
  6. ^ "A vaccine for Alzheimer's is on the verge of becoming a reality". www.wired.co.uk. Retrieved October 11, 2019.
  7. ^ "About United BioPharma". www.unitedbiopharma.com. Retrieved October 11, 2019.
  8. ^ "UBI Pharma Company Overview". www.ubi-pharma.com. Retrieved October 11, 2019.
  9. ^ "Global Grand Challenges". gcgh.grandchallenges.org. Retrieved October 11, 2019.

External links